Anti-inflammatory and Antioxidant Effects of Kaempferia galanga Extract in Acute Bacterial Rhinosinusitis: In Vivo Study on MDA, NF-κB, and CRP

Articles in Press

Document Type : Original

Authors

1 Doctoral Program of Medical Science, Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Surakarta, Indonesia Departement of Otorhinolaryngology, Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Indonesia.

2 Doctoral Program of Medical Science, Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Surakarta, Indonesia. Parasitology and Micology Department, Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Indonesia.

3 Doctoral Program of Medical Science, Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Surakarta, Indonesia Department of Internal Medicine, Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Indonesia

4 Doctoral Program of Medical Science, Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Surakarta, Indonesia Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Indonesia

5 Doctoral Program of Medical Science, Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Surakarta, Indonesia Department of Microbiology, Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Indonesia

6 Doctoral Program of Medical Science, Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Surakarta, Indonesia Department of Oral Disease, Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Indonesia

7 Departement of Otorhinolaryngology, Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Indonesia

10.22038/ijorl.2025.90356.4019

Abstract

Introduction:
Acute bacterial rhinosinusitis (ABRS) is an inflammation of the paranasal sinuses caused by bacterial infection, primarily involving inflammatory responses and oxidative stress. While antibiotics are the standard treatment, their effectiveness can sometimes be limited. Kaempferia galanga (K. galanga), a medicinal plant known for its anti-inflammatory and antioxidant properties, has shown potential as a therapeutic agent. This study aimed to evaluate the therapeutic efficacy of K. galanga extract in a mouse model of ABRS.
Materials and Methods:
An in vivo experimental study was conducted using Sprague-Dawley rats with induced ABRS. The animals were randomly divided into three treatment groups that received K. galanga extract at doses of 150 mg/kg (KG150), 300 mg/kg (KG300), or 450 mg/kg (KG450) based on body weight. Therapeutic effects were assessed by measuring serum levels of MDA, NF-κB, and CRP.
Results:
Eighteen rats with ABRS were included in the study. The KG300 group exhibited significantly lower levels of MDA, NF-κB, and CRP compared to the KG150 and KG450 groups (p < 0.05). These findings suggest that the 300 mg/kg dose of K. galanga extract provides optimal therapeutic benefit.
Conclusion:
K. galanga extract at 300 mg/kg demonstrated the most potent anti-inflammatory and antioxidant effects in a mouse model of ABRS, indicating its potential as an effective alternative or adjunctive therapy.

Keywords

Main Subjects

References

  1. Huriyati E, Darwin E, Yanwirasti Y, Wahid I. Association of inflammation mediator in mucosal and tissue of chronic rhinosinusitis with recurrent nasal polyp. Open Access Maced J Med Sci. 2019; 7(10):1635–40.
  2. Rapiejko P, Talik P, Jurkiewicz D. New treatment options for acute rhinosinusitis according to EPOS 2020. Otolaryngol Pol. 2021;76(1):29–39.
  3. Tai J, Shin JM, Park J, Han M, Kim TH. Oxidative Stress and antioxidants in chronic rhinosinusitis with nasal polyps. Antioxidants. 2023; 12(1):195.
  4. Wardani ATW, Purwanto B, Indarto D, Wasita B, Risya Cilmiaty AR. Effect of moringa leaf ethanol extract on reduced levels of MDA, TNF-α and description of inflammatory cells in rat sinus mucosa model of acute rhinosinusitis. Bangladesh J Med Sci. 2022;21(2):311–7.
  5. Cheng N, Wang Y, Gu Z. Understanding the role of NLRP3-mediated pyroptosis in allergic rhinitis: A review. Biomed Pharmacother. 2023; 165: 115203.
  6. Elshamy AI, Mohamed TA, Essa AF, Abd-El Gawad AM, Alqahtani AS, Shahat AA, et al. Recent advances in kaempferia phytochemistry and biological activity: A comprehensive review. Nutrients. 2019;11(10):2396.
  7. Wang SY, Zhao H, Xu HT, Han XD, Wu YS, Xu FF, et al. Kaempferia galanga L.: Progresses in phytochemistry, pharmacology, toxicology and ethnomedicinal uses. Front Pharmacol. 2021;12:
  8. Umar MI, Asmawi MZ, Sadikun A, Majid AMSA, Al-Suede FSR, Hassan LEA, et al. Ethyl-p-methoxycinnamate isolated from kaempferia galanga inhibits inflammation by suppressing interleukin-1, tumor necrosis factor-α, and angiogenesis by blocking endothelial functions. Clinics. 2014;69(2):134–44.
  9. Dwita LP, Hikmawanti NPE, Yeni, Supandi. Extract, fractions, and ethyl-p-methoxycinnamate isolate from Kaempferia galanga Elicit anti-inflammatory activity by limiting leukotriene B4 (LTB4) production. J Tradit Complement Med. 2021;11(6):563–9.
  10. Wang SY, Cai L, Yang N, Xu FF, Wu YS, Liu B. Chemical composition of the Kaempferia galanga L. essential oil and its in vitro and in vivo antioxidant activities. Front Nutr. 2023;10:1080487.
  11. Patel ZM, Hwang PH. Acute bacterial rhinosinusitis. In: Durand ML, Deschler DG, editors. Infections of the ears, nose, throat, and sinuses. Cham: Springer International Publishing; 2018. p. 133–43.
  12. Nurmala S, Elfrieda NSAL, Zaddana C, Ali AA. Anti-inflammation effectiveness of ginger (Kaemferia galanga l.) and shallots (Allium ascalonicum l.) extract combination on sprague-dawley male rat. FJIF. 2024;14(1):44–50.
  13. Wang S, Yang J, Cai L, Li H, Han X, Liu B, et al. Antioxidant effect of ethyl acetate fraction from Kaempferia galanga L.: Integrated Phytochemical profiling, network analysis, and experimental validation. Antioxidants. 2025;14(5):551.
  14. Piski Z, Gerlinger I, Nepp N, Farkas K, Weber R. TNF-alpha inhibitors and rhinosinusitis-A systematic review and meta-analysis. Am J Rhinol Allergy. 2020;34(3):436–42.
  15. Tiboc Schnell CN, FILIP GA, Decea N, Moldovan R, Opris R, Man SC, et al. The impact of Sambucus nigra L. extract on inflammation, oxidative stress and tissue remodeling in a rat model of lipopolysaccharide-induced subacute rhinosinusitis. Inflammopharmacology. 2021; 29(3):753–69.
  16. Hendradewi S, Purwanto B, Dirgahayu P, Wasita B, Pamungkas EP. The effect of Escherichia Coli induction on superoxide dismutase (SOD) and malondialdehyde (MDA) levels in acute rhinosinusitis white rats models. Bali Med J. 2020; 9(2): 542–5.
  17. Alrumaihi F, Almatroodi SA, Alharbi HOA, Alwanian WM, Alharbi FA, Almatroudi A, et al. Pharmacological potential of kaempferol, a flavonoid in the management of pathogenesis via modulation of inflammation and other biological activities. Molecules. 2024;29(9):2007.
  18. Herrera TES, Tello IPS, Mustafa MA, Jamil NY, Alaraj M, Atiyah Altameem KK, et al. Kaempferol: Unveiling its anti-inflammatory properties for therapeutic innovation. Cytokine. 2025;186:156846.
  19. Sotler R, Poljšak B, Dahmane R, Jukic T, Jukic DP, Rotim C, et al. Prooxidant activities of antioxidants and their impact on health. Acta Clin Croat. 2019;58(4):726-36.
  20. Nowak M, Tryniszewski W, Sarniak A, Wlodarczyk A, Nowak PJ, Nowak D. Concentration dependence of anti- and pro-oxidant activity of polyphenols as evaluated with a light-emitting Fe2+-Egta-H2O2 system. Molecules. 2022; 27(11): 3453.
  21. Stiller CO, Hjemdahl P. Lessons from 20 years with COX-2 inhibitors: Importance of dose-response considerations and fair play in comparative trials. J Intern Med. 2022;292(4):557-74.
  22. Samodra G, Febrina D. The comparison between anti-inflammatory effects of ethanol extract from Kaempferia galanga L. and diclofenac sodium induced by carrageenan. In: 1st International Conference on Community Health (ICCH 2019). Atlantis Press; 2020:18-22.
  23. Jagadish PC, Latha KP, Mudgal J, Nampurath GK. Extraction, characterization and evaluation of Kaempferia galanga L. (Zingiberaceae) rhizome extracts against acute and chronic inflammation in rats. J Ethnopharmacol. 2016;194:434-9.

 

 

 

 

Iranian Journal of Otorhinolaryngology

Articles in Press, Corrected Proof
Available Online from 25 December 2025

Files

Share

How to cite

Statistics